Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health TechnologyHAO -13.51%21 3-Year RORE % is -90.97 as of Dec. 2025. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 954 Media - Diversified companies, Haoxi Health Technology ranks worse than 88.16% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Haoxi Health Technology's 3-Year RORE % for the quarter that ended in Dec. 2025 was -90.97%.
The industry rank for Haoxi Health Technology's 3-Year RORE % or its related term are showing as below:
HAO's 3-Year RORE % is ranked worse than 88.16% of 954
companies
in the Media - Diversified industry
Industry Median: -2.355
vs HAO: -90.97
Haoxi Health Technology (NAS:HAO) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Haoxi Health Technology 3-Year RORE % Related Terms
Haoxi Health Technology 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Advertising Agencies subindustry, Haoxi Health Technology's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haoxi Health Technology 3-Year RORE % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Haoxi Health Technology's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Haoxi Health Technology (HAO) has a 3-Year RORE % of -90.97 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Haoxi Health Technology and its competitors. According to the industry distribution chart, Haoxi Health Technology ranks #841 out of 954 companies in the Media - Diversified industry, placing it in the top 88.2%.
Is Haoxi Health Technology's 3-Year RORE % too high?
Haoxi Health Technology's current 3-Year RORE % is -90.97. Based on the distribution chart, Haoxi Health Technology ranks #841 out of 954 companies in the Media - Diversified industry, which is in the bottom quartile relative to peers. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's 3-Year RORE % compare to BAOS and DBMM?
According to the Media - Diversified industry distribution chart, Haoxi Health Technology ranks #841 out of 954 companies for 3-Year RORE %. This places Haoxi Health Technology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Media - Diversified company?
A good 3-Year RORE % depends on the Media - Diversified industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Haoxi Health Technology and its competitors. Haoxi Health Technology's current 3-Year RORE % is -90.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current 3-Year RORE % of -90.97. The current 3-Year RORE % is -90.97. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current 3-Year RORE % is -90.97 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
